A detailed history of Redpoint Investment Management Pty LTD transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Redpoint Investment Management Pty LTD holds 5,950 shares of VRTX stock, worth $2.68 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
5,950
Previous 6,981 14.77%
Holding current value
$2.68 Million
Previous $1.97 Million 12.4%
% of portfolio
0.25%
Previous 0.23%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 14, 2022

SELL
$273.83 - $305.53 $282,318 - $315,001
-1,031 Reduced 14.77%
5,950 $1.72 Million
Q2 2022

Jul 08, 2022

SELL
$234.96 - $292.55 $17,622 - $21,941
-75 Reduced 1.06%
6,981 $1.97 Million
Q1 2022

Apr 13, 2022

SELL
$221.42 - $260.97 $29,006 - $34,187
-131 Reduced 1.82%
7,056 $1.84 Million
Q3 2021

Nov 12, 2021

SELL
$181.39 - $202.99 $25,575 - $28,621
-141 Reduced 1.92%
7,187 $1.3 Million
Q2 2021

Aug 05, 2021

BUY
$187.49 - $221.1 $18,936 - $22,331
101 Added 1.4%
7,328 $1.48 Million
Q1 2021

Apr 13, 2021

BUY
$207.02 - $241.31 $96,885 - $112,933
468 Added 6.92%
7,227 $1.55 Million
Q4 2020

Jan 13, 2021

SELL
$207.01 - $276.09 $94,396 - $125,897
-456 Reduced 6.32%
6,759 $1.6 Million
Q3 2020

Oct 09, 2020

SELL
$255.65 - $303.1 $3.07 Million - $3.64 Million
-12,000 Reduced 62.45%
7,215 $1.96 Million
Q2 2020

Jul 17, 2020

SELL
$225.48 - $295.8 $318,828 - $418,261
-1,414 Reduced 6.85%
19,215 $5.58 Million
Q1 2020

Apr 22, 2020

SELL
$199.77 - $247.81 $33,361 - $41,384
-167 Reduced 0.8%
20,629 $4.91 Million
Q4 2019

Feb 25, 2020

SELL
$166.71 - $223.91 $103,026 - $138,376
-618 Reduced 2.89%
20,796 $4.55 Million
Q3 2019

Nov 26, 2019

SELL
$166.23 - $187.09 $63,167 - $71,094
-380 Reduced 1.74%
21,414 $3.63 Million
Q2 2019

Aug 07, 2019

SELL
$164.61 - $190.37 $47,407 - $54,826
-288 Reduced 1.3%
21,794 $4 Million
Q1 2019

May 14, 2019

BUY
$163.73 - $194.7 $183,213 - $217,869
1,119 Added 5.34%
22,082 $4.06 Million
Q2 2018

Aug 09, 2018

BUY
$145.72 - $169.96 $68,342 - $79,711
469 Added 2.29%
20,963 $3.56 Million
Q4 2017

Aug 09, 2018

BUY
$137.28 - $155.55 $2.81 Million - $3.19 Million
20,494
20,494 $3.07 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Redpoint Investment Management Pty LTD Portfolio

Follow Redpoint Investment Management Pty LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redpoint Investment Management Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Redpoint Investment Management Pty LTD with notifications on news.